[en] rClinically-relevant pituitary adenomas occur in about 1:1000 of the general population, but only about 5% occur in a known genetic or familial setting. Familial isolated pituitary adenomas (FIPA) are one of the most important inherited settings for pituitary adenomas and the most frequent genetic cause is a germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene. AIP mutations lead to young-onset macroadenomas that are difficult to treat. Most are growth hormone secreting tumors, but all other secretory types can exist and the clinical profile of affected patients is variable. We present an overview of the current understanding of AIP mutation-related pituitary disease and illustrate various key clinical factors using examples from one of the largest AIP mutation-positive FIPA families identified to date, in which six mutation-affected members with pituitary disease have been diagnosed. We highlight various clinically significant features of FIPA and AIP mutations, including issues related to patients with acromegaly, prolactinoma, apoplexy and non-functioning pituitary adenomas. The challenges faced by these AIP mutation-positive patients due to their disease and the long-term outcomes in older patients are discussed. Similarly, the pitfalls encountered due to incomplete penetrance of pituitary adenomas in AIP-mutated kindreds are discussed.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Bilbao Garay, Ismene
Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Egaña Zunzunegi, Nerea
Beckers, Albert ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Language :
English
Title :
Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview
Daly, A.F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M.A., Beckers, A., High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium (2006) J. Clin. Endocrinol. Metab, 91, pp. 4769-4775. , [CrossRef]
Gruppetta, M., Mercieca, C., Vassallo, J., Prevalence and incidence of pituitary adenomas: A population based study in Malta (2012) Pituitary, 16, pp. 545-553. , [CrossRef]
Vandeva, S., Daly, A.F., Petrossians, P., Zacharieva, S., Beckers, A., Genetics in endocrinology: Somatic and germline mutations in the pathogenesis of pituitary adenomas (2019) Eur. J. Endocrinol, 181, pp. R235-R254. , [CrossRef]
Beckers, A., Familial isolated pituitary adenomas. The Ninth International Workshop on Multiple Endocrine Neoplasia (MEN2004) (2004) J. Intern. Med, 255, pp. 696-730
Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., Valdes-Socin, H., Rohmer, V., Tamburrano, G., Borson-Chazot, C., Brue, T., Clinical Characterization of Familial Isolated Pituitary Adenomas (2006) J. Clin. Endocrinol. Metab, 91, pp. 3316-3323. , [CrossRef] [PubMed]
Valdes-Socin, H., Stevens, V., Stevenaert, A., Beckers, A.P.J., Adenomes hypophysaires familiaux isoles non lies avec la mutation somatique NEM-1. Suivi de 27 patients (2000) Ann. d’Endocrinol, 61, p. 301
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Paschke, R., Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene (2006) Science, 312, pp. 1228-1230. , [CrossRef] [PubMed]
Daly, A.F., Vanbellinghen, J.-F., Khoo, S., Jaffrain-Rea, M.L., Naves, L.A., Guitelman, M., Murat, A., Tamburrano, G., Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families (2007) J. Clin. Endocrinol. Metab, 92, pp. 1891-1896. , [CrossRef] [PubMed]
Beckers, A., Lodish, M.B., Trivellin, G., Rostomyan, L., Lee, M., Faucz, F.R., Yuan, B., Verrua, E., X-linked acrogigantism syndrome: Clinical profile and therapeutic responses (2015) Endocr. Relat. Cancer, 22, pp. 353-367. , [CrossRef] [PubMed]
Trivellin, G., Daly, A.F., Faucz, F.R., Yuan, B., Rostomyan, L., Larco, D.O., Schernthaner-Reiter, M.H., Caberg, J.-H., Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation (2014) N. Engl. J. Med, 371, pp. 2363-2374. , [CrossRef] [PubMed]
Daly, A.F., Tichomirowa, M.A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.L., Barlier, A., Naves, L.A., Raappana, A., Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIPMutations and Pituitary Adenomas: An International Collaborative Study (2010) J. Clin. Endocrinol. Metab, 95, pp. E373-E383. , [CrossRef] [PubMed]
Rostomyan, L., Daly, A.F., Petrossians, P., Nachev, E., Lila, A.R., Lecoq, A.-L., Lecumberri, B., Moraitis, A.G., Clinical and genetic characterization of pituitary gigantism: An international collaborative study in 208 patients (2015) Endocr. Relat. Cancer, 22, pp. 745-757. , [CrossRef]
Beckers, A., Aaltonen, L.A., Daly, A.F., Karhu, A., Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene (2013) Endocr. Rev, 34, pp. 239-277. , [CrossRef] [PubMed]
Hernández-Ramírez, L.C., Gabrovska, P., Dénes, J., Stals, K., Trivellin, G., Tilley, D., Ferraù, F., Grossman, A.B., Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers (2015) J. Clin. Endocrinol. Metab, 100, pp. E1242-E1254. , [CrossRef] [PubMed]
Cuny, T., Pertuit, M., Sahnoun-Fathallah, M., Daly, A.F., Occhi, G., Odou, M.-F., Tabarin, A., Rohmer, V., Genetic analysis in young patients with sporadic pituitary macroadenomas: Besides AIP don’t forget MEN1 genetic analysis (2013) Eur. J. Endocrinol, 168, pp. 533-541. , [CrossRef] [PubMed]
Villa, C., Lagonigro, M.S., Magri, F., Koziak, M., Jaffrain-Rea, M.L., Brauner, R., Bouligand, J., Sainte-Rose, C., Hyperplasia–adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation (2011) Endocr. Relat. Cancer, 18, pp. 347-356. , [CrossRef] [PubMed]
Tichomirowa, M.A., Barlier, A., Daly, A.F., Jaffrain-Rea, M.L., Ronchi, C.L., Yaneva, M., Urban, J.D., Tabarin, A., High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas (2011) Eur. J. Endocrinol, 165, pp. 509-515. , [CrossRef]
Daly, A.F., Rostomyan, L., Betea, D., Bonneville, J.F., Villa, C., Pellegata, N.S., Waser, B., Christ, E., AIP-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide LAR in two patients (2019) Endocr. Connect, 8, pp. 367-377. , [CrossRef]
Igreja, S., Chahal, H.S., King, P., Bolger, G.B., Srirangalingam, U., Guasti, L., Chapple, J., Guegan, K., Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families (2010) Hum. Mutat, 31, pp. 950-960. , [CrossRef]
Xekouki, P., Mastroyannis, S.A., Avgeropoulos, D., Sierra, M.D.L.L., Trivellin, G., Gourgari, E.A., Lyssikatos, C., Kanaka-Gantenbein, C., Familial pituitary apoplexy as the only presentation of a novel AIP mutation (2013) Endocr. Relat. Cancer, 20, pp. L11-L14. , [CrossRef]
Liu, Z.-H., Chang, C.N., Pai, P.C., Wei, K.C., Jung, S.M., Chen, N.Y., Chuang, C.C., Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy (2010) J. Clin. Neurosci, 17, pp. 694-699. , [CrossRef] [PubMed]
Onesti, S.T., Wisniewski, T., Post, K.D., Clinical versus Subclinical Pituitary Apoplexy: Presentation, Surgical Management, and Outcome in 21 Patients (1990) Neurosurgery, 26, pp. 980-986. , [CrossRef] [PubMed]
Roerink, S.H., Van Lindert, E.J., Van De Ven, A.C., Spontaneous remission of acromegaly and Cushing’s disease following pituitary apoplexy: Two case reports (2015) Neth. J. Med, 73, pp. 242-246. , [PubMed]
Georgitsi, M., Karhu, A., Winqvist, R., Visakorpi, T., Waltering, K., Vahteristo, P., Launonen, V., Aaltonen, L., Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers (2007) Br. J. Cancer, 96, pp. 352-356. , [CrossRef] [PubMed]
Igreja, S., Chahal, H.S., Akker, S.A., Gueorguiev, M., Popovic, V., Damjanovic, S., Burman, P., Grossman, A.B., Assessment ofp27(cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectableMEN1gene mutations (2009) Clin. Endocrinol, 70, pp. 259-264. , [CrossRef]
Raitila, A., Georgitsi, M., Karhu, A., Tuppurainen, K., Mäkinen, M.J., Birkenkamp-Demtröder, K., Salmenkivi, K., Launonen, V., No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia (2007) Endocr. Relat. Cancer, 14, pp. 901-906. , [CrossRef]
Leontiou, C.A., Gueorguiev, M., Van Der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H.S., Rowe, J., The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas (2008) J. Clin. Endocrinol. Metab, 93, pp. 2390-2401. , [CrossRef]
Guaraldi, F., Corazzini, V., Gallia, G.L., Grottoli, S., Stals, K., Dalantaeva, N., Frohman, L.A., Salvatori, R., Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor (2012) Pituitary, 15, pp. 61-67. , [CrossRef]
Coopmans, E.C., Muhammad, A., Daly, A.F., De Herder, W.W., Van Kemenade, F.J., Beckers, A., De Haan, M., Neggers, S.J.C.M.M., The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: A nationwide pathology registry (PALGA) study (2020) Endocrine, pp. 1-10. , [CrossRef]
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Edfors, F., A pathology atlas of the human cancer transcriptome (2017) Science, 357, p. eaan2507. , [CrossRef]
Vasilev, V., Daly, A.F., Trivellin, G., Stratakis, C.A., Zacharieva, S., Beckers, A., The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA) (2020) Endocr. Relat. Cancer, , [CrossRef] [PubMed]
Naves, L.A., Daly, A.F., Vanbellinghen, J.-F., Casulari, L.A., Spilioti, C., Magalhães, A.V., Azevedo, M.F., Nunes, R.O., Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene (2007) Eur. J. Endocrinol, 157, pp. 383-391. , [CrossRef] [PubMed]
Ezzat, S., Asa, S.L., Couldwell, W.T., Barr, C.E., Dodge, W.E., Vance, M.L., McCutcheon, I.E., The prevalence of pituitary adenomas: A systematic review (2004) Cancer, 101, pp. 613-619. , [CrossRef] [PubMed]
Marques, P., Caimari, F., Hernández-Ramírez, L.C., Collier, D., Iacovazzo, D., Ronaldson, A., Magid, K., Ellard, S., Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors (2020) J. Clin. Endocrinol. Metab, 105, p. 105. , [CrossRef]
